Healthcare provider profile · identity verified

Mark Micek, MD

Internal Medicine · MADISON, WI · NPI 1871620468

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	554	140
Amlodipine Besylate	Amlodipine Besylate	333	81
Gabapentin	Gabapentin	266	61
Omeprazole	Omeprazole	244	68
Levothyroxine Sodium	Levothyroxine Sodium	226	54
Lisinopril	Lisinopril	215	63
Rosuvastatin Calcium	Rosuvastatin Calcium	208	54
Losartan Potassium	Losartan Potassium	152	45
Carvedilol	Carvedilol	150	37
Tamsulosin Hcl	Tamsulosin Hcl	150	37
Eliquis	Apixaban	149	29
Oxycodone Hcl	Oxycodone Hcl	142	20
Pantoprazole Sodium	Pantoprazole Sodium	130	26
Potassium Chloride	Potassium Chloride	129	31
Metoprolol Succinate	Metoprolol Succinate	115	26
Valsartan	Valsartan	115	33
Jardiance	Empagliflozin	114	23
Sertraline Hcl	Sertraline Hcl	109	23
Hydrochlorothiazide	Hydrochlorothiazide	103	37
Duloxetine Hcl	Duloxetine Hcl	99	24
Ozempic	Semaglutide	96	13
Famotidine	Famotidine	95	24
Fluticasone Propionate	Fluticasone Propionate	91	34
Metformin Hcl Er	Metformin Hcl	91	26
Tizanidine Hcl	Tizanidine Hcl	91	13
Allopurinol	Allopurinol	88	21
Furosemide	Furosemide	87	19
Chlorthalidone	Chlorthalidone	85	23
Albuterol Sulfate Hfa	Albuterol Sulfate	71	24
Lorazepam	Lorazepam	61	20
Ezetimibe	Ezetimibe	60	12
Simvastatin	Simvastatin	59	17
Trazodone Hcl	Trazodone Hcl	58	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	18
Celecoxib	Celecoxib	56	14
Spironolactone	Spironolactone	56	14
Fluoxetine Hcl	Fluoxetine Hcl	49	11
Warfarin Sodium	Warfarin Sodium	49	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	15
Pravastatin Sodium	Pravastatin Sodium	48	12
Quetiapine Fumarate	Quetiapine Fumarate	48	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	47	11
Buspirone Hcl	Buspirone Hcl	46	suppressed
Finasteride	Finasteride	46	11
Metoprolol Tartrate	Metoprolol Tartrate	46	suppressed
Bupropion Xl	Bupropion Hcl	44	11
Hydralazine Hcl	Hydralazine Hcl	43	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Baclofen	Baclofen	41	suppressed
Glipizide Er	Glipizide	40	12
Montelukast Sodium	Montelukast Sodium	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	11
Escitalopram Oxalate	Escitalopram Oxalate	38	13
Metformin Hcl	Metformin Hcl	38	11
Pregabalin	Pregabalin	38	suppressed
Clonazepam	Clonazepam	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Eszopiclone	Eszopiclone	33	suppressed
Ondansetron Odt	Ondansetron	33	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	27
Tramadol Hcl	Tramadol Hcl	32	suppressed
Valacyclovir	Valacyclovir Hcl	28	suppressed
Methadone Hcl	Methadone Hcl	27	suppressed
Prednisone	Prednisone	27	13
Trulicity	Dulaglutide	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	11
Donepezil Hcl	Donepezil Hcl	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Cephalexin	Cephalexin	22	13
Lansoprazole	Lansoprazole	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	18
Estradiol	Estradiol	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Atenolol	Atenolol	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Diazepam	Diazepam	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Aripiprazole	Aripiprazole	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Naproxen	Naproxen	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Insulin Aspart	Insulin Aspart	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Mexiletine Hcl	Mexiletine Hcl	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error